Cargando…
Prolonged response to first-line erlotinib for advanced lung adenocarcinoma
A 58-year-old, non-smoking female of Philippine origin presented with painful thoracic and neck nodal relapse of lung adenocarcinoma almost 5 years after left pneumonectomy for stage II non-small-cell lung cancer. She refused conventional chemotherapy or radiation because of toxicity concerns, but a...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612645/ https://www.ncbi.nlm.nih.gov/pubmed/18983643 http://dx.doi.org/10.1186/1756-9966-27-59 |